László A.
- Country
- Hungary
- Department
- Gyermekszív Kozpont
Research Overview
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study with Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged ≥2 to <18 years with Pulmonary Arterial Hypertension
- A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR)
- Long-term Safety Evaluation of Tadalafil and Macitentan in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Data & Insights
Has run more than one trial at 64 of 127 partner sites.
Specializations
Pulmonary Vascular Medicine
The investigator specializes in treating pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Their research encompasses therapeutic interventions for both adult and pediatric populations.
- Long-term disease management
- Pediatric PAH treatments
- Novel therapeutic approaches
Particular focus is placed on evaluating innovative treatment options for children with pulmonary vascular disorders.
Pediatric Cardiology
The investigator conducts research in heart failure due to left ventricular systolic dysfunction in pediatric patients. Their work includes assessment of new therapeutic agents for improving cardiac function in children.
- Pediatric heart failure management
- Systolic dysfunction treatments
- Long-term cardiac care
The research extends to monitoring long-term safety and efficacy outcomes in pediatric cardiac patients.
Pediatric Infectious Disease
The investigator studies preventive treatments for respiratory syncytial virus (RSV) in high-risk pediatric populations. Their work focuses on evaluating protective interventions for vulnerable infants and children.
- RSV prevention strategies
- High-risk infant protection
- Comparative treatment efficacy
Special attention is given to safety assessment and tolerability of preventive treatments in the pediatric population.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.